Tzvika Ilan, Founder and Partner at MediMe AI
Technology company MediMe AI has recently been conducting discussions regarding investments totaling tens of millions of dollars and the establishment of joint ventures. The company reported that in recent weeks, dozens of agencies and insurance agents who approached MediMe AI seeking to join its customer base under a SaaS model were informed that the company has temporarily halted marketing its system to private agents and agencies. According to market estimates, this move is linked to ongoing talks MediMe is holding with overseas investors.
The move is expected to expand the use of MediMe AI’s technology beyond its current core focus in health insurance into additional insurance segments, including risk insurance, loss of work capacity, property, and P&C insurance.
It was further reported that the company is in negotiations with two insurance companies and an additional insurance entity in the Israeli market.
The planned investment in MediMe’s Israeli operations is intended to accelerate the company’s Hub & Spoke strategy: replicating core capabilities proven in health insurance across all insurance lines. The goal is to create a “single source of truth” for data for each insured individual and to enable smart data cross-referencing across health, motor, home, and life insurance policies. In addition, MediMe’s system performs data mining on existing customer portfolios, identifying “dark data” (dormant opportunities) and gaps in insurance coverage.
MediMe AI stated: “MediMe AI provides the most advanced technology in the field for the benefit of its clients and insureds. Without addressing specific transactions, we can say that, in general, we are continuously receiving inquiries regarding cooperation and investment, and are holding discussions with leading parties who have recognized and understood the strength and uniqueness of our technology as a basis for building a commercial relationship.”
